MVision AI: your data is protected!
MVision AI not only provides unique AI-powered solutions for Radiotherapy treatment planning but also follows the highest standards of data protection for clinics and their…
Read more Posts by Saad
Deep learning to generate synthetic CT Images from MR for Radiotherapy treatment planning
The generation of synthetic images has greatly advanced in recent years due to the progress of artificial intelligence. Some of the applications have recently been…
Read more NCCC Evaluation of MVision AI contouring software
S Warren, N Richmond MVision AI software has been under evaluation at NCCC (Newcastle upon Tyne Hospitals NHS Foundation Trust) since 28 February 2022* in…
Read more MVision: 2022 year in review
2022 came to an end. Seeing our names of customers, the number of scans and countries marked on the map, we know, we reached our…
Read more Distribution partnership agreement between MVision AI and Tecnosan
Finland, Helsinki, December 14, 2022 – MVision AI, the leading provider of AI-powered Guideline Based Segmentation solution for Radiotherapy planning and Tecnosan, advanced healthcare technology…
Read more Cancer in Ireland – Raising Survival Rates
Every year, almost 45.000 people in Ireland are diagnosed with cancer, making Ireland the country with the highest cancer incidence in Europe. The 5 most…
Read more MVision’s GBS™ is Featured in 5 Posters at the German Society of Radiation Oncology (DEGRO) Annual Meeting
This week, we’re focusing on high-impact research presented during the German Society of Radiation Oncology (DEGRO) Annual Meeting. Five posters included a focus on MVision’s…
Read more Improving Tools to Fight Glioblastoma
Background Glioblastoma multiforme represents approximately half of the cases of central nervous system malignant tumors. The median age at diagnosis is 64 years, and the…
Read more RT for Prostate Cancer: Faster and Better – Is it Possible?
Background Worldwide, more than 1 400 000 men were diagnosed with prostate cancer in 2020, and it is estimated that one third will need radiotherapy…
Read more MVision AI Receives FDA 510(k) Clearance for Guideline-Based Segmentation Radiotherapy Software
Helsinki, 31st of May, 2022 – MVision AI announces that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for guideline-based, AI-powered…
Read more